Curve Biosciences: Funding, Investors & Team (Sep 2026)
Curve Biosciences specializes in precision medicine for chronic diseases, led by a team of experts like Nathan Hunkapiller, PhD, and Chuba Oyolu, PhD. They are at the forefront of biotechnology research, focusing on developing targeted solutions for chronic diseases and emphasizing the importance of precision in treatment. The company is dedicated to improving patient outcomes through innovative research in the biotechnology industry.
Curve Biosciences has raised $57.7M across 2 funding rounds on record, the most recent a Series A of $40.0M announced in Oct 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Curve Biosciences Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Curve Biosciences Funding Rounds
Curve Biosciences raised $17.7M in an undisclosed round announced in May 2024.
1.4 years later, a Series A of $40.0M was announced in Oct 2025.
Curve Biosciences Founders and Leadership Team
Contact details for the Curve Biosciences team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Curve Biosciences Funding Compared to Other Biotechnology Startups
Curve Biosciences' latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Curve Biosciences in Biotechnology and Mountain View
Companies Similar to Curve Biosciences
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Curve Biosciences Funding FAQs
What does Curve Biosciences do?
Curve Biosciences specializes in precision medicine for chronic diseases, led by a team of experts like Nathan Hunkapiller, PhD, and Chuba Oyolu, PhD. They are at the forefront of biotechnology research, focusing on developing targeted solutions for chronic diseases and emphasizing the importance of precision in treatment. The company is dedicated to improving patient outcomes through innovative research in the biotechnology industry.
How much funding has Curve Biosciences raised?
Curve Biosciences has raised $57.7M across 2 rounds on record. The most recent is a Series A of $40.0M announced in Oct 2025.
When did Curve Biosciences last raise funding?
Curve Biosciences' most recent funding round on record is a Series A of $40.0M, announced in Oct 2025.
Who founded Curve Biosciences?
FundedIQ lists Chuba Oyolu (Founder) at Curve Biosciences.
Who is the CEO of Curve Biosciences?
Ritish Patnaik is listed as CEO at Curve Biosciences.
Where is Curve Biosciences headquartered?
Curve Biosciences is based in Mountain View, California, United States.
How many employees does Curve Biosciences have?
Curve Biosciences is in the 1-10 employee band.
How does Curve Biosciences' funding compare to other Biotechnology startups?
Curve Biosciences' latest round of $40.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Curve Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Curve Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.